Evaluation of the BARD® True™ Flow Valvuloplasty Perfusion Catheter for Aortic Valve Dilatation

CompletedOBSERVATIONAL
Enrollment

25

Participants

Timeline

Start Date

September 30, 2016

Primary Completion Date

October 31, 2016

Study Completion Date

October 31, 2016

Conditions
Aortic Valve Stenosis
Interventions
DEVICE

True™ Flow Valvuloplasty Perfusion Catheter

Balloon Aortic Valvuloplasty as preparation step in implantation of a Tanscatheter Aortic Valve Implantation (TAVI).

Trial Locations (1)

04289

Leipzig Heart Institute GmbH, Leipzig

Sponsors

Lead Sponsor

All Listed Sponsors
lead

C. R. Bard

INDUSTRY

NCT02847546 - Evaluation of the BARD® True™ Flow Valvuloplasty Perfusion Catheter for Aortic Valve Dilatation | Biotech Hunter | Biotech Hunter